Dianomi Therapeutics, Inc.
Madison, WI · Founded 2017 · CIK 0001737087 · Biotech · Private
Mineral-coated microparticle (MCM) delivery system for sustained protein therapeutics, demonstrated with anakinra for gout treatment
- Grants
- $252K
- 1 award
- Sector median: 1
- Raised
- $185K
- 1 Form D · Apr 2018
- 102 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 8
- 0 granted · 8 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20172018201920202021
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $185,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Dianomi Therapeutics - Using Mineral Coated Microparticles as an Improved Sustained Delivery Method of Anakinra for Treatment and Prevention of Gout with a Single Injection | $251,880 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1209 | MIRNATECH INTERNATIONAL, INC. | — | — |
| 1210 | VIVASC THERAPEUTICS INC | — | — |
| 1211 | AUGMENTA BIOWORKS, INC. | — | — |
| 1212 | Dianomi Therapeutics, Inc. | — | $185K |
| 1213 | Novoglia, Inc. | — | $37M |
| 1214 | Matrubials, Inc. | — | — |
| 1215 | MADRIGAL PHARMACEUTICALS, INC. | — | $35M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Carter CliffDirector · Executive Officer
- Kurtis KnappDirector · Executive Officer
- Barry KurokawaDirector · Executive Officer
- William MurphyDirector · Executive Officer
Patents
- Mineral Coated Microparticles For Sustained Delivery Of Steroidsapplication
- Compositions And Methods For Vaccine Deliveryapplication
- Inorganic Coatings For The Sustained Release Of Bioactive Compoundsapplication
- Methods For Treating Or Preventing Inflammatory Eventsapplication
- Compositions And Methods For Vaccine Deliveryapplication
- Inorganic Coatings For The Sustained Release Of Bioactive Compoundsapplication
- Methods For Treating Or Preventing Inflammatory Eventsapplication
- Mineral Coated Microparticles For Sustained Delivery Of Steroidsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.